Its table attributes elevated gallbladder disease risk to rapid weight loss rather than the medication alone, stating the effect is most common in patients losing more than 5 kg
L-Carnitine is synthesized in the brain, liver and kidney, with muscle being the main tissue reservoir [21,22,23]
Glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s, have moved rapidly from medical treatment to mainstream conversation
Faster dose escalation does not speed weight loss and significantly increases nausea, vomiting, and gastrointestinal side effects without additional benefit
Roche's enicepatide (CT-388) is the strongest on raw efficacy
References Collins, Logan, and Ryan A Costello